Thierry Guillaudeux
Chief Scientific Officer · KINETA, INC./DE
Individual
- 2025
- Jun 30, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Thierry Guillaudeux's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thierry Guillaudeux?
Thierry Guillaudeux is a corporate insider, tracked as Chief Scientific Officer of KINETA, INC./DE (KANT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thierry Guillaudeux last file a Form 4?
The only primary Form 4 on record is dated 30 June 2025.
